These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12857479)

  • 1. [Changes of liver function in patients with severe viral hepatitis before and after treatment with hematological replacement therapy].
    Shen JJ; Wang YG; Gu BQ; Liu SL; Zhang ZL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Feb; 15(2):122. PubMed ID: 12857479
    [No Abstract]   [Full Text] [Related]  

  • 2. [Change of blood parameters in liver failure patients with severe hepatitis after combined therapy].
    Lin JH; Guo YX; Zhou XH; Chen FS
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Feb; 15(2):103-5. PubMed ID: 12857471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of blood coagulation test in fulminant hepatic failure].
    Kawamura A; Meguro J; Kukita K; Yonekawa M; Imai K; Kobayashi N; Kawamura K; Kasai M
    Hokkaido Igaku Zasshi; 1988 Sep; 63(5):805-10. PubMed ID: 3240924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects evaluation of middle mode artificial liver in treatment of severe hepatitis].
    He NH; Wang YJ; Liu J; Li JJ; Liu GD; Wang YM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jan; 16(1):6-8. PubMed ID: 14706192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of severe hepatitis by artificial liver support system].
    Ming Q; Qiu SQ; Chen CY; Luo SX; Zhou J; Bai L
    Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):315. PubMed ID: 15161522
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of plasma exchange on serum cytokines in severe viral hepatitis patients].
    He J; Xu TM; Zhou GP; Wang YZ; Pan TJ; Chen GC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Feb; 15(2):106-8. PubMed ID: 12857473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of treatment with continuous renal replacement therapy on severe hepatitis with hepatic encephalopathy].
    Zhao WF; Gan JH; Xu J; Jiang MH; Zhu X; Luo EP; Wu JC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Feb; 15(2):109-13. PubMed ID: 12857474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MELD scoring system for predicting prognosis in patients with severe hepatitis after plasma exchange treatment.
    Yu JW; Wang GQ; Zhao YH; Sun LJ; Wang SQ; Li SC
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):492-6. PubMed ID: 17897912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of plasma replacement on the hepatic failure with infection].
    Song MN; Luo ML; Min F
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Feb; 15(2):120-1. PubMed ID: 12857478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis comparison in middle and later stage severe hepatitis B patients treat with plasma exchange or unified medicine therapy].
    Chen GC; Zhang SC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Oct; 24(5):370-2. PubMed ID: 21280328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of plasma exchange combined with fetal hepacyties on viral hepatitis gravis].
    Zheng XH; Tang XP; Chen J
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):437-9. PubMed ID: 12536493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical research of plasma exchange with continuous veno-venous hemofiltration in treating mid- and late-stage chronic severe viral hepatitis B patients].
    Ye WJ; Li LJ; Yu HY; Zhang XP; Tian J; Bai MH
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):370-3. PubMed ID: 15918974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exchange in cholestatic hepatitis.
    Menini C; Ruberti A; Reverberi R; Cantarini D
    Riv Emoter Immunoematol; 1983; 30(1):50-5. PubMed ID: 6635480
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oxygen therapy in the combined treatment of patients with chronic cholecystitis combined with hepatitis].
    Miagkov II; Zhura II; Okhrimovich LM; Pokin'chereda VV; Khandoga TN
    Vrach Delo; 1984 Nov; (11):96-9. PubMed ID: 6528569
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prediction, diagnosis and therapy of fulminant hepatitis].
    Muto Y; Murakami N; Sugihara J
    Nihon Naika Gakkai Zasshi; 1990 Aug; 79(8):1012-7. PubMed ID: 2230480
    [No Abstract]   [Full Text] [Related]  

  • 16. [Liver diseases. C 1. Fulminant hepatitis: the present status and major problems of its therapeutic intervention].
    Muto Y
    Nihon Naika Gakkai Zasshi; 1982 May; 71(5):599-603. PubMed ID: 7130804
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes of plasma cytokines in patients with severe hepatitis treated with a probiotic preparation].
    Lu MQ; Zheng Y; Chen YP; Li J; Ye HH
    Zhonghua Gan Zang Bing Za Zhi; 2008 Apr; 16(4):283-5. PubMed ID: 18423151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical uses of plasma exchange therapy in some diseases].
    Han Z; Lu H; Huang Y; Liu A; Pei M
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(6):553-4. PubMed ID: 10073008
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alcoholic hepatitis].
    Braillon A; Davion T; Tribout B; Capron JP
    Rev Prat; 1986 Sep; 36(39):2276-80. PubMed ID: 3809926
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of scanning to evaluate the effectiveness of therapy in chronic hepatitis and liver cirrhosis].
    Baramidze TG; Samadashvili AG; Rostomova LT
    Med Radiol (Mosk); 1970 Jun; 15(6):49-54. PubMed ID: 5432892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.